Works matching IS 09509232 AND DT 2013 AND VI 32 AND IP 23

Results: 10

The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia.

Published in:

Oncogene, 2013, v. 32, n. 23, p. 2805, doi. 10.1038/onc.2012.411

By:

Malek, S N

Publication type:

Article

HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade.

Published in:

Oncogene, 2013, v. 32, n. 23, p. 2828, doi. 10.1038/onc.2013.32

By:

Kim, Y J;
Greer, C B;
Cecchini, K R;
Harris, L N;
Tuck, D P;
Kim, T H

Publication type:

Article

Annexin A6 is a scaffold for PKCα to promote EGFR inactivation.

Published in:

Oncogene, 2013, v. 32, n. 23, p. 2858, doi. 10.1038/onc.2012.303

By:

Koese, M;
Rentero, C;
Kota, B P;
Hoque, M;
Cairns, R;
Wood, P;
Vilà de Muga, S;
Reverter, M;
Alvarez-Guaita, A;
Monastyrskaya, K;
Hughes, W E;
Swarbrick, A;
Tebar, F;
Daly, R J;
Enrich, C;
Grewal, T

Publication type:

Article

Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockade.

Published in:

Oncogene, 2013, v. 32, n. 23, p. 2873, doi. 10.1038/onc.2012.302

By:

Kasper, S;
Breitenbuecher, F;
Reis, H;
Brandau, S;
Worm, K;
Köhler, J;
Paul, A;
Trarbach, T;
Schmid, K W;
Schuler, M

Publication type:

Article

Carboxypeptidase E: a negative regulator of the canonical Wnt signaling pathway.

Published in:

Oncogene, 2013, v. 32, n. 23, p. 2836, doi. 10.1038/onc.2012.308

By:

Skalka, N;
Caspi, M;
Caspi, E;
Loh, Y P;
Rosin-Arbesfeld, R

Publication type:

Article

The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer.

Published in:

Oncogene, 2013, v. 32, n. 23, p. 2882, doi. 10.1038/onc.2012.297

By:

Ezponda, T;
Popovic, R;
Shah, M Y;
Martinez-Garcia, E;
Zheng, Y;
Min, D-J;
Will, C;
Neri, A;
Kelleher, N L;
Yu, J;
Licht, J D

Publication type:

Article

Real-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors.

Published in:

Oncogene, 2013, v. 32, n. 23, p. 2818, doi. 10.1038/onc.2012.304

By:

Bagci-Onder, T;
Agarwal, A;
Flusberg, D;
Wanningen, S;
Sorger, P;
Shah, K

Publication type:

Article

Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer.

Published in:

Oncogene, 2013, v. 32, n. 23, p. 2891, doi. 10.1038/onc.2012.300

By:

Hulf, T;
Sibbritt, T;
Wiklund, E D;
Patterson, K;
Song, J Z;
Stirzaker, C;
Qu, W;
Nair, S;
Horvath, L G;
Armstrong, N J;
Kench, J G;
Sutherland, R L;
Clark, S J

Publication type:

Article

The gain of function of p53 cancer mutant in promoting mammary tumorigenesis.

Published in:

Oncogene, 2013, v. 32, n. 23, p. 2900, doi. 10.1038/onc.2012.299

By:

Lu, X;
Liu, D P;
Xu, Y

Publication type:

Article

Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway.

Published in:

Oncogene, 2013, v. 32, n. 23, p. 2848, doi. 10.1038/onc.2012.306

By:

Adesso, L;
Calabretta, S;
Barbagallo, F;
Capurso, G;
Pilozzi, E;
Geremia, R;
Delle Fave, G;
Sette, C

Publication type:

Article